if your calcs are correct this gives me confidence we'll beat placebo.

I'm regularly seeing published figures that place mortality rates in the 20%+ on average.

I'm very confident in Leron's ability to prevent mortality in treatment arm.

You have to remember that not only was the motefiore patients extremely ill, but so were the UCLA patients as well as the patients in the other hospital.

And when I say extremely ill, i mean they have multiple comorbidities, tried other treatments and failed, were triaged and were given leronlimab at an extremely late stage in their disease process.

I hope your calcs are correct because if so they bring me great confidence.